A trial of G-CSF therapy in heart patients has produced beneficial results. [ + ]

A recently established postgraduate course at Monash University is giving students the skills and experience they need to turn scientific research into commercial viability.

Siemens Medical Solutions Diagnostics, the first 'full service diagnostics' company in the world, will begin operation in Australia and New Zealand on 1 June.

Embattled WA biotech Chemeq has finally folded after several years of disastrous financial performance. [ + ]

A system able to deliver drugs straight to the heart of conscious patients has won a local award. [ + ]

CSIRO Plant Industry and NZ's AgResearch are putting their heads together. [ + ]

Australia's first preclinical contract R&D facility, TetraQ, was officially launched today to help speed the movement of medicines out of the laboratory and into the marketplace.

Austrian company Intercell has announced the completion of the phase I study of its Staphylococcus aureus vaccine.

An international research consortium has identified four genes believed to increase susceptibility to breast cancer. [ + ]

The Lomb Group has recently been appointed the national distributor for the Eppendorf range of products.

The government has introduced the Global Opportunities program, promising $254.1 million over 10 years to help Australian companies become global businesses.

The Australian Institute for Commercialisation (AIC) and the Australian Nano Business Forum (ANBF) have combined to help raise industry awareness of the potential of nanotechnology.

Scientists from New Zealand and Australia have used mountains as giant ‘dipsticks’ to analyse the history of the world's largest ice sheet.

The hunt for Wobbly is on. [ + ]

US researchers have constructed the first family tree of metabolic protein architecture. [ + ]